North Tide Capital’s AbbVie ABBV Stock Holding History

North Tide Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-500,000	Closed	-$32.7M	–	21
2014 Q4	$32.7M	Sell	500,000 -1,000,000	-67%	-$63M	2.2%	17
2014 Q3	$86.6M	Buy	+1,500,000	New	+$83.3M	6.6%	3

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

North Tide Capital's ABBV Position: Q1 2015 in Review

North Tide Capital sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 500,000 shares — an estimated $32.7M sold.

North Tide Capital first reported a position in ABBV in Q3 2014 and held it in 2 quarters. The position peaked at $86.6M in Q3 2014. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

North Tide Capital reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
North Tide Capital sold 500,000 AbbVie shares in Q1 2015, an estimated $32.7M.
North Tide Capital first reported a position in AbbVie in Q3 2014 and held it in 2 quarters.
North Tide Capital's AbbVie position peaked at $86.6M in Q3 2014.
1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on North Tide Capital's 13F filing for Q1 2015, filed 15 May 2015.